These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 7969905
1. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Carpenedo R, Chiarugi A, Russi P, Lombardi G, Carlà V, Pellicciari R, Mattoli L, Moroni F. Neuroscience; 1994 Jul; 61(2):237-43. PubMed ID: 7969905 [Abstract] [Full Text] [Related]
2. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. Chiarugi A, Carpenedo R, Molina MT, Mattoli L, Pellicciari R, Moroni F. J Neurochem; 1995 Sep; 65(3):1176-83. PubMed ID: 7643095 [Abstract] [Full Text] [Related]
3. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. Pellicciari R, Natalini B, Costantino G, Mahmoud MR, Mattoli L, Sadeghpour BM, Moroni F, Chiarugi A, Carpenedo R. J Med Chem; 1994 Mar 04; 37(5):647-55. PubMed ID: 8126705 [Abstract] [Full Text] [Related]
4. Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity. Connick JH, Heywood GC, Sills GJ, Thompson GG, Brodie MJ, Stone TW. Gen Pharmacol; 1992 Mar 04; 23(2):235-9. PubMed ID: 1639238 [Abstract] [Full Text] [Related]
5. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase. Chiarugi A, Carpenedo R, Moroni F. J Neurochem; 1996 Aug 04; 67(2):692-8. PubMed ID: 8764597 [Abstract] [Full Text] [Related]
6. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K. Br J Pharmacol; 1998 May 04; 124(2):391-9. PubMed ID: 9641558 [Abstract] [Full Text] [Related]
7. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus. Miranda AF, Sutton MA, Beninger RJ, Jhamandas K, Boegman RJ. Neurosci Lett; 1999 Mar 05; 262(2):81-4. PubMed ID: 10203236 [Abstract] [Full Text] [Related]
8. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Miranda AF, Boegman RJ, Beninger RJ, Jhamandas K. Neuroscience; 1997 Jun 05; 78(4):967-75. PubMed ID: 9174065 [Abstract] [Full Text] [Related]
9. Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo. Wu HQ, Guidetti P, Goodman JH, Varasi M, Ceresoli-Borroni G, Speciale C, Scharfman HE, Schwarcz R. Neuroscience; 2000 Jun 05; 97(2):243-51. PubMed ID: 10799756 [Abstract] [Full Text] [Related]
10. Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions. Russi P, Alesiani M, Lombardi G, Davolio P, Pellicciari R, Moroni F. J Neurochem; 1992 Dec 05; 59(6):2076-80. PubMed ID: 1431895 [Abstract] [Full Text] [Related]
12. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, Moroni F. Eur J Neurosci; 2001 Jun 05; 13(11):2141-7. PubMed ID: 11422455 [Abstract] [Full Text] [Related]
13. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase. Chiarugi A, Moroni F. Neuropharmacology; 1999 Aug 05; 38(8):1225-33. PubMed ID: 10462134 [Abstract] [Full Text] [Related]
14. Role of kynurenines in the neurotoxic actions of kainic acid. Behan WM, Stone TW. Br J Pharmacol; 2000 Apr 05; 129(8):1764-70. PubMed ID: 10780984 [Abstract] [Full Text] [Related]
15. Modulation and function of kynurenic acid in the immature rat brain. Schwarcz R, Ceresoli-Borroni G, Wu HQ, Rassoulpour A, Poeggeler B, Hodgkins PS, Guidetti P. Adv Exp Med Biol; 1999 Apr 05; 467():113-23. PubMed ID: 10721048 [Abstract] [Full Text] [Related]
16. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum. Urenjak J, Obrenovitch TP. J Neurochem; 2000 Dec 05; 75(6):2427-33. PubMed ID: 11080194 [Abstract] [Full Text] [Related]
17. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. Carpenedo R, Meli E, Peruginelli F, Pellegrini-Giampietro DE, Moroni F. J Neurochem; 2002 Sep 05; 82(6):1465-71. PubMed ID: 12354294 [Abstract] [Full Text] [Related]
19. Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. Moroni F, Russi P, Gallo-Mezo MA, Moneti G, Pellicciari R. J Neurochem; 1991 Nov 05; 57(5):1630-5. PubMed ID: 1833509 [Abstract] [Full Text] [Related]
20. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase. Giordani A, Corti L, Cini M, Bormetti R, Marconi M, Veneroni O, Speciale C, Varasi M. Adv Exp Med Biol; 1996 Nov 05; 398():531-4. PubMed ID: 8906317 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]